We are live on ! Find out more
VWM

Valley Wealth Managers Portfolio holdings

AUM $1.55B
1-Year Est. Return 28.47%
This Fund
S&P 500
This Quarter Est. Return
-10.84%
1 Year Est. Return
+28.47%
3 Year Est. Return
+80.1%
5 Year Est. Return
+107.99%
10 Year Est. Return
+332.91%
AUM
$765M
AUM Growth
-$81.1M
Cap. Flow
+$19.6M
Cap. Flow %
2.56%
Top 10 Hldgs %
24.98%
Holding
173
New
57
Increased
50
Reduced
57
Closed
6

Top Sells

Rank Stock Value
1
EMN icon
Eastman Chemical
EMN
+$16.3M
2
OSK icon
Oshkosh
OSK
+$15.3M
3
TRV icon
Travelers Companies
TRV
+$14.6M
4
CRI icon
Carter's
CRI
+$5.02M
5
LKQ icon
LKQ Corp
LKQ
+$4.8M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Healthcare 18.42%
3 Financials 14.25%
4 Industrials 8.04%
5 Consumer Discretionary 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
26
Microchip Technology
MCHP
$44.2B
$14.6M 1.91%
407,022
-6,908
-2% -$244K
MSFT icon
27
Microsoft
MSFT
$2.83T
$13.9M 1.81%
136,735
+2,402
+2% +$257K
PFE icon
28
Pfizer
PFE
$143B
$13.7M 1.78%
329,656
+103,751
+46% +$4.31M
BLK icon
29
Blackrock
BLK
$161B
$13.4M 1.75%
34,034
-134
-0.4% -$54.9K
XOM icon
30
ExxonMobil
XOM
$650B
$13M 1.7%
190,719
-18,461
-9% -$1.45M
STWD icon
31
Starwood Property Trust
STWD
$6.05B
$12.9M 1.69%
654,459
-38,230
-6% -$824K
WFC icon
32
Wells Fargo
WFC
$261B
$12.9M 1.68%
279,437
-9,767
-3% -$500K
LH icon
33
Labcorp
LH
$23.9B
$12.8M 1.67%
117,910
-4,233
-3% -$567K
COR icon
34
Cencora
COR
$59.4B
$12.1M 1.58%
162,547
-13,727
-8% -$1.18M
CVS icon
35
CVS Health
CVS
$136B
$11.8M 1.54%
179,787
-10,783
-6% -$805K
WP
36
DELISTED
Worldpay, Inc.
WP
$11.4M 1.49%
149,418
-405
-0.3% -$35.2K
INGR icon
37
Ingredion
INGR
$6.32B
$11.4M 1.49%
124,876
-7,615
-6% -$762K
APTV icon
38
Aptiv
APTV
$11.9B
$11.1M 1.44%
179,562
-1,543
-0.9% -$112K
ARRS
39
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$11M 1.44%
360,810
-13,750
-4% -$382K
ST icon
40
Sensata Technologies
ST
$6.63B
$8.98M 1.17%
+200,357
New +$9.07M
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$7.8M 1.02%
31,224
+30,144
+2,791% +$8.13M
CRI icon
42
Carter's
CRI
$1.38B
$7.71M 1.01%
94,491
-55,215
-37% -$5.02M
LKQ icon
43
LKQ Corp
LKQ
$6.32B
$6.56M 0.86%
276,544
-176,507
-39% -$4.8M
JPM icon
44
JPMorgan Chase
JPM
$930B
$4.35M 0.57%
44,526
+11,167
+33% +$1.19M
PG icon
45
Procter & Gamble
PG
$342B
$4.17M 0.55%
45,414
+15,447
+52% +$1.38M
INTC icon
46
Intel
INTC
$504B
$3.75M 0.49%
79,936
+12,801
+19% +$599K
MRK icon
47
Merck
MRK
$322B
$3.35M 0.44%
45,891
+5,961
+15% +$421K
PEP icon
48
PepsiCo
PEP
$184B
$3.21M 0.42%
29,057
+12,884
+80% +$1.45M
IWF icon
49
iShares Russell 1000 Growth ETF
IWF
$123B
$2.99M 0.39%
91,496
+3,360
+4% +$118K
ABBV icon
50
AbbVie
ABBV
$454B
$2.89M 0.38%
31,321
+1,736
+6% +$153K

Similar funds

Valley Wealth Managers's Q4 2018 Portfolio in Review

As of Q4 2018, Valley Wealth Managers held 173 positions worth $765M, down 9.6% from $846M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Valley Wealth Managers's Q4 2018 filing shows 57 new, 50 increased, 57 reduced and 6 closed positions. Its largest new stake was Celanese: 175,898 shares worth $15.8M. The largest sale was Eastman Chemical, an estimated $16.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Valley Wealth Managers's largest Q4 2018 buy was Celanese: 175,898 shares worth $15.8M.
  • Valley Wealth Managers added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $8.13M increase.
  • Valley Wealth Managers's biggest Q4 2018 reduction was Travelers Companies, cutting an estimated $14.6M.
  • Valley Wealth Managers fully exited Eastman Chemical in Q4 2018, selling an estimated $16.3M.
  • Valley Wealth Managers's ten largest holdings make up 25% of its $765M portfolio in Q4 2018.
  • Valley Wealth Managers opened 57 new positions and closed 6 in Q4 2018.
  • Valley Wealth Managers's portfolio value fell 9.6% quarter-over-quarter to $765M.

Based on Valley Wealth Managers's 13F filing for Q4 2018, filed 8 Feb 2019.